PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryMay 8, 2002	Integra LifeSciences Reports First Quarter Earnings Per Share of $0.13 on Record Revenues of $25.9 Million Integra LifeSciences Reports First Quarter Earnings Per Share of $0.13 on Record Revenues of $25.9 Million PLAINSBORO, N.J., May 8, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported record revenues of $25.9 million and net income of $0.13 per share for the	View HTML Integra LifeSciences Reports First Quarter Earnings Per Share of $0.13 on Record Revenues of $25.9 Million 18.2 KB
Toggle SummaryJul 15, 2002	Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge Plainsboro, New Jersey, July 15, 2002-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Absorbable Collagen Sponge	View HTML Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge 12.4 KB
Toggle SummaryJul 29, 2002	Integra LifeSciences Schedules Conference Call for Tuesday, August 6 to Discuss Second Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance; Announces Participation in Adams, Harkness & Hill Annual Summer Seminar Integra LifeSciences Schedules Conference Call for Tuesday, August 6 to Discuss Second Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance; Announces Participation in Adams, Harkness & Hill Annual Summer Seminar PLAINSBORO, N.J.-July 29, 2002-- Integra LifeSciences Holdings	View HTML Integra LifeSciences Schedules Conference Call for Tuesday, August 6 to Discuss Second Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance; Announces Participation in Adams, Harkness & Hill Annual Summer Seminar 10.5 KB
Toggle SummaryAug 1, 2002	Integra LifeSciences Reports Second Quarter Earnings Per Share of $0.14 on Record Revenues of $26.4 Million Integra LifeSciences Reports Second Quarter Earnings Per Share of $0.14 on Record Revenues of $26.4 Million PLAINSBORO, N.J., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record revenues of $26.4 million and net income of $0.14 per share for the	View HTML Integra LifeSciences Reports Second Quarter Earnings Per Share of $0.14 on Record Revenues of $26.4 Million 14.8 KB
Toggle SummaryAug 1, 2002	Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business PLAINSBORO, N.J., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the	View HTML Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business 14.8 KB
Toggle SummaryAug 1, 2002	Integra LifeSciences Announces Acquisition of Signature Technologies, a Specialty Manufacturer of Neurosurgical and Spinal Implants Integra LifeSciences Announces Acquisition of Signature Technologies, a Specialty Manufacturer of Neurosurgical and Spinal Implants PLAINSBORO, N.J. and Pembroke, Mass., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the	View HTML Integra LifeSciences Announces Acquisition of Signature Technologies, a Specialty Manufacturer of Neurosurgical and Spinal Implants 14.8 KB
Toggle SummaryAug 6, 2002	Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents PLAINSBORO, N.J., Aug. 6, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) and REVA Medical, Inc.	View HTML Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents 13.9 KB
Toggle SummarySep 18, 2002	Integra LifeSciences Holdings Corporation Appoints David C. Auth to Board of Directors Integra LifeSciences Holdings Corporation Appoints David C. Auth to Board of Directors Plainsboro, NJ / September 18, 2002 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that effective October 31, 2002 it will increase the size of its Board of Directors to six and	View HTML Integra LifeSciences Holdings Corporation Appoints David C. Auth to Board of Directors 10.7 KB
Toggle SummarySep 24, 2002	Integra NeuroSciences Announces Launch of Camino® Single Parameter Monitor in Europe and Other International Markets Integra NeuroSciences Announces Launch of Camino® Single Parameter Monitor in Europe and Other International Markets Plainsboro, NJ / September 24, 2002/ -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Integra NeuroSciences has launched the Camino&reg; Single	View HTML Integra NeuroSciences Announces Launch of Camino® Single Parameter Monitor in Europe and Other International Markets 12.5 KB
Toggle SummarySep 24, 2002	Integra LifeSciences Announces Acquisition of the NeuroSensorT Monitor and Related Technology from Novus Monitoring Limited Integra LifeSciences Announces Acquisition of the NeuroSensorT Monitor and Related Technology from Novus Monitoring Limited Plainsboro, NJ / September 23, 2002 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has acquired certain assets, including the	View HTML Integra LifeSciences Announces Acquisition of the NeuroSensorT Monitor and Related Technology from Novus Monitoring Limited 12.5 KB